People

Vertex ousts longtime exec Ian Smith over unspecified code of conduct violations

There's some big trouble to report at Boston-based Vertex, a bellwether company in the biotech industry.

The cystic fibrosis drug developer announced after the market closed Wednesday that they had ousted company COO and CFO Ian Smith for conduct unbecoming an executive at the company.

Ian Smith Handout photo



In order to read this article, you must be an Endpoints News subscriber. (It's free to subscribe.)

← Go back

We produce two daily email newsletters designed to give you a complete picture of what's important in biopharma. It's free to subscribe and never any spam. Join 42,100+ biopharma executives who read Endpoints News every day.

Access is subject to the terms in our Privacy Policy.


The best place to read Endpoints News? In your inbox.

Comprehensive daily news report for those who discover, develop, and market drugs. Join 42,100+ biopharma pros who read Endpoints News by email every day.

Free Subscription

Head of Business Development
Wren Therapeutics Boston, MA
Life Sciences Venture Professional
Northpond Ventures Washington, DC
Senior Drug Discovery Oncologist
Schrödinger New York, NY

Visit Endpoints Careers ->